Signet ring cell carcinoma of the stomach

Yoshihiko Maehara, Yoshihisa Sakaguchi, Sunao Moriguchi, Hiroyuki Orita, Daisuke Korenaga, Shunji Kohnoe, Keizo Sugimachi

Research output: Contribution to journalArticle

122 Citations (Scopus)

Abstract

Between 1965 and 1985, 51 of 1500 patients (3.4%) with gastric cancer who had gastric resection had signet ring cell gastric cancer. Patients with this form of cancer tended to be younger and female; the tumors were smaller and involved the stomach body, serosal invasion was less prominent, and lymph node metastases were less likely to be present. Early mucosal and submucosal cancer was present in 54.9% of the patients with the signet ring cell and in 24.6% with other types of gastric cancer. In 15.7% of patients with signet ring cell cancer, a noncurative resection was performed. The 5‐year survival rate was 74.5% for patients with signet ring cell cancer and 52.4% for those with other types of gastric cancer (P < 0.01). In patients with signet ring cell gastric cancer, the lesion is less extensive; thus, these patients probably can expect a longer survival time.

Original languageEnglish
Pages (from-to)1645-1650
Number of pages6
JournalCancer
Volume69
Issue number7
DOIs
Publication statusPublished - Apr 1 1992

Fingerprint

Signet Ring Cell Carcinoma
Stomach
Stomach Neoplasms
Neoplasms
Survival Rate
Lymph Nodes
Neoplasm Metastasis
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Maehara, Y., Sakaguchi, Y., Moriguchi, S., Orita, H., Korenaga, D., Kohnoe, S., & Sugimachi, K. (1992). Signet ring cell carcinoma of the stomach. Cancer, 69(7), 1645-1650. https://doi.org/10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X

Signet ring cell carcinoma of the stomach. / Maehara, Yoshihiko; Sakaguchi, Yoshihisa; Moriguchi, Sunao; Orita, Hiroyuki; Korenaga, Daisuke; Kohnoe, Shunji; Sugimachi, Keizo.

In: Cancer, Vol. 69, No. 7, 01.04.1992, p. 1645-1650.

Research output: Contribution to journalArticle

Maehara, Y, Sakaguchi, Y, Moriguchi, S, Orita, H, Korenaga, D, Kohnoe, S & Sugimachi, K 1992, 'Signet ring cell carcinoma of the stomach', Cancer, vol. 69, no. 7, pp. 1645-1650. https://doi.org/10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X
Maehara Y, Sakaguchi Y, Moriguchi S, Orita H, Korenaga D, Kohnoe S et al. Signet ring cell carcinoma of the stomach. Cancer. 1992 Apr 1;69(7):1645-1650. https://doi.org/10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X
Maehara, Yoshihiko ; Sakaguchi, Yoshihisa ; Moriguchi, Sunao ; Orita, Hiroyuki ; Korenaga, Daisuke ; Kohnoe, Shunji ; Sugimachi, Keizo. / Signet ring cell carcinoma of the stomach. In: Cancer. 1992 ; Vol. 69, No. 7. pp. 1645-1650.
@article{9c5fd4cf04d94cc3bc6dca66b0ce4c68,
title = "Signet ring cell carcinoma of the stomach",
abstract = "Between 1965 and 1985, 51 of 1500 patients (3.4{\%}) with gastric cancer who had gastric resection had signet ring cell gastric cancer. Patients with this form of cancer tended to be younger and female; the tumors were smaller and involved the stomach body, serosal invasion was less prominent, and lymph node metastases were less likely to be present. Early mucosal and submucosal cancer was present in 54.9{\%} of the patients with the signet ring cell and in 24.6{\%} with other types of gastric cancer. In 15.7{\%} of patients with signet ring cell cancer, a noncurative resection was performed. The 5‐year survival rate was 74.5{\%} for patients with signet ring cell cancer and 52.4{\%} for those with other types of gastric cancer (P < 0.01). In patients with signet ring cell gastric cancer, the lesion is less extensive; thus, these patients probably can expect a longer survival time.",
author = "Yoshihiko Maehara and Yoshihisa Sakaguchi and Sunao Moriguchi and Hiroyuki Orita and Daisuke Korenaga and Shunji Kohnoe and Keizo Sugimachi",
year = "1992",
month = "4",
day = "1",
doi = "10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X",
language = "English",
volume = "69",
pages = "1645--1650",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Signet ring cell carcinoma of the stomach

AU - Maehara, Yoshihiko

AU - Sakaguchi, Yoshihisa

AU - Moriguchi, Sunao

AU - Orita, Hiroyuki

AU - Korenaga, Daisuke

AU - Kohnoe, Shunji

AU - Sugimachi, Keizo

PY - 1992/4/1

Y1 - 1992/4/1

N2 - Between 1965 and 1985, 51 of 1500 patients (3.4%) with gastric cancer who had gastric resection had signet ring cell gastric cancer. Patients with this form of cancer tended to be younger and female; the tumors were smaller and involved the stomach body, serosal invasion was less prominent, and lymph node metastases were less likely to be present. Early mucosal and submucosal cancer was present in 54.9% of the patients with the signet ring cell and in 24.6% with other types of gastric cancer. In 15.7% of patients with signet ring cell cancer, a noncurative resection was performed. The 5‐year survival rate was 74.5% for patients with signet ring cell cancer and 52.4% for those with other types of gastric cancer (P < 0.01). In patients with signet ring cell gastric cancer, the lesion is less extensive; thus, these patients probably can expect a longer survival time.

AB - Between 1965 and 1985, 51 of 1500 patients (3.4%) with gastric cancer who had gastric resection had signet ring cell gastric cancer. Patients with this form of cancer tended to be younger and female; the tumors were smaller and involved the stomach body, serosal invasion was less prominent, and lymph node metastases were less likely to be present. Early mucosal and submucosal cancer was present in 54.9% of the patients with the signet ring cell and in 24.6% with other types of gastric cancer. In 15.7% of patients with signet ring cell cancer, a noncurative resection was performed. The 5‐year survival rate was 74.5% for patients with signet ring cell cancer and 52.4% for those with other types of gastric cancer (P < 0.01). In patients with signet ring cell gastric cancer, the lesion is less extensive; thus, these patients probably can expect a longer survival time.

UR - http://www.scopus.com/inward/record.url?scp=0026562451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026562451&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X

DO - 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X

M3 - Article

C2 - 1312889

AN - SCOPUS:0026562451

VL - 69

SP - 1645

EP - 1650

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -